Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. For over 65 years, the company has pioneered breakthrough technologies that transform cardiovascular care, specializing in artificial heart valves and hemodynamic monitoring solutions. Edwards develops, manufactures, and markets medical devices that address the most critical needs of patients fighting cardiovascular disease, serving millions of patients across more than 100 countries worldwide.
The company's groundbreaking work in transcatheter aortic heart valve replacement (TAVR) pioneered an innovative, life-changing solution for patients by offering heart valve replacement without the need for open heart surgery. Edwards' Transcatheter Heart Valve (THV) business unit continues to partner with cardiologists and clinical teams to transform patient care with devices supported by rigorous clinical evidence. The company's Advanced Technology teams harness imagination, courage, and resourcefulness to create solutions for patients many years into the future, maintaining an unwavering commitment to patient-focused innovation that helps people live longer and healthier lives.